ADVERTISEMENT
Image representing states of consciousness
High Time: The Roles of Endogenous Psychedelics
Steven Barker is on a forty-seven-year-long journey to understand the mind-blowing science of psychedelics.
High Time: The Roles of Endogenous Psychedelics
High Time: The Roles of Endogenous Psychedelics

Steven Barker is on a forty-seven-year-long journey to understand the mind-blowing science of psychedelics.

Steven Barker is on a forty-seven-year-long journey to understand the mind-blowing science of psychedelics.

pharmacology

A cross-section of mouse brain showing the locus coeruleus in fluorescent green
Hormone Sobers Up Drunken Mice: Study
Alejandra Manjarrez, PhD | Mar 8, 2023 | 3 min read
A hormone naturally induced by alcohol consumption accelerates the recovery of mice after binge drinking by activating neurons involved in arousal and alertness.
Man with blue shirt and tie smiling at camera.
Pharmacologist and Olympian David Bailey Dies at 77
Lisa Winter | Oct 7, 2022 | 3 min read
He was best known for his discovery that grapefruit juice makes some medications less effective or potentially dangerous.
Building Advanced Cell Models for Toxicity Testing
Building Advanced Cell Models for Toxicity Testing
The Scientist Staff | 1 min read
In this webinar, Kevin Grady and Manisha Nautiyal will outline how to make predictive 2D and 3D models for pharmacological toxicity testing.  
pharmacology medicine parkinson's disease dopamine l-dopa levodopa Hornykiewicz obituary
Oleh Hornykiewicz, Who Pioneered Treatment for Parkinson’s, Dies
Amanda Heidt | Jun 18, 2020 | 3 min read
The University of Toronto and University of Vienna pharmacologist developed L-dopa, a precursor to dopamine that remains the most widely used therapy for Parkinson’s disease.
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020 | 3 min read
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
Discover the Benefits to Using Label-Free Techniques to Study Biomolecular Interactions
Why Label-Free Techniques Can Help Researchers Study Biomolecular Interactions in Real-Time
Sartorius | 1 min read
Surface plasmon resonance and Bio-layer interferometry offer advantages when investigating biological mechanisms and developing new therapeutics.
Lipid Expert and Babraham Institute Director Michael Wakelam Dies
Amy Schleunes | Apr 7, 2020 | 2 min read
Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.
mdma ecstacy serotonin dopamine
Serotonin and Dopamine Responsible for the Pros and Cons of MDMA
Ruth Williams | Dec 11, 2019 | 3 min read
A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.
Building a Synthetic Biology Platform for Drug Delivery
Building a Synthetic Biology Platform for Drug Delivery
The Scientist | 1 min read
Kate Adamala and Niren Murthy will discuss the latest advances in drug delivery using synthetic biology approaches.
an illustration of dividing cancer cells
Cancer Drugs in Development May Be Targeting Wrong Proteins
Shawna Williams | Sep 12, 2019 | 3 min read
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Hydrogel injected near tumors help recruit cancer drugs to the site
Image of the Day: Right on Target
Nicoletta Lanese | Jul 23, 2019 | 1 min read
An injectable biomaterial calls cancer drugs to tumor sites in mice.
One Size Does Not Fit All: Pharmacogenomics in Precision Medicine
The Scientist | 1 min read
Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019 | 3 min read
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
head shot of Anthony Fauci
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018 | 3 min read
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Perfecting Dose Response Assays
The Scientist | 1 min read
Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018 | 10+ min read
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018 | 3 min read
Researchers use several different strategies to deliver a one-two punch.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018 | 3 min read
The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Nasser Zawia: An American Scientist Born in Yemen
Bob Grant | Mar 23, 2017 | 4 min read
The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 
ADVERTISEMENT